Pacific Biosciences of California PACB Business Segments — Other income, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's business segments — other income, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacific Biosciences of California's business segments — other income, net?
- Pacific Biosciences of California (PACB) reported business segments — other income, net of $266K in Q1 2026.
- How has Pacific Biosciences of California's business segments — other income, net changed year-over-year?
- Pacific Biosciences of California's business segments — other income, net decreased by 89.6% year-over-year, from $2.56M to $266K.
- What is the long-term trend for Pacific Biosciences of California's business segments — other income, net?
- Over 3 years (2022 to 2025), Pacific Biosciences of California's business segments — other income, net has grown at a 3.4% compound annual growth rate (CAGR), from -$7.05M to $7.8M.
- What does business segments — other income, net mean?
- This represents the net balance of non-operating income and expenses generated by the reportable segment, excluding core revenue and operating costs. It typically includes items such as interest income, foreign exchange gains or losses, and other miscellaneous financial activities not directly tied to the primary business operations. Monitoring this helps investors understand the impact of peripheral financial activities on the segment's overall bottom line.